Conseil d'examen du prix des médicaments brevetés - Patented Medicine Prices Review Board Canada Wordmark
 
 Français  Contact Us  Help  Search  Canada Site
Home About the
 PMPRB
Order Forms
Feedback
Sitemap
Archives
 Other Sites

Home > What's New Printer Friendly

What's New @ PMPRB

To order any publication, please include this form or call our toll-free number 1-877-861-2350.

   RECORDS PER PAGE

Reminder - November 27-29
The Board continues its hearing into the price of Risperdal Consta.

The public hearing in the matter of Janssen-Ortho Inc, and the medicine Risperdal Consta is scheduled to continue November 27 to 29, 2006, starting at 9:30 a.m., in the Board's Offices, 333 Laurier Avenue West, 18th floor, Hearing Room #2, Ottawa.  For more information, please contact the Secretary of the Board at (613) 954-8299.




Release of the October 2006 NEWSletter
 


The PMPRB releases its second quarterly report on Non-Patented Prescription Drug Prices, Trends in Canadian Sales and Market Structure.
 


AIROMIR Hearing, scheduled for October 16-19, 2006, has been postponed.

The public hearing in the matter of 3M Canada Company and the medicine Airomir, scheduled to start on October 16, has been postponed.  An update will be posted as soon as a hearing date has been confirmed.  For more information, please contact the Secretary of the Board at (613) 954-8299 or at sdupont@pmprb-cepmb.gc.ca.




September 28-29
The Board continues its hearing into the price of Risperdal Consta.

The public hearing in the matter of Janssen-Ortho Inc, and the medicine Risperdal Consta is scheduled to continue September 28 and 29, 2006, starting at 9:30 a.m., in the Board's Offices, 333 Laurier Avenue West, 18th floor, Hearing Room #1, Ottawa.  For more information, please contact the Secretary of the Board at (613) 954-8299.




Release of the July 2006 NEWSletter
 


The Board has accepted three VCUs - NuvaRing™ - Eloxatin - Hextend

The Board has accepted three Voluntary Compliance Undertakings (VCUs) for the medicines:




Ministerial Announcement: Dr. Brien G. Benoit named Chairperson of the Board and Mary Catherine Lindberg, Vice-Chairperson
 


The Airomir Hearing, scheduled to start July 13, 2006, has been postponed.
 


The PMPRB releases its first quarterly report on Non-Patented Prescription Drug Prices, Canadian and Foreign Price Trends.
 


PAGE 1 - 2 - 3 - 4 - 5  NEXT 50  LAST 10 


Last Updated: 2004-04-14 Arrow Important Notices